Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance
Go back to Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 300.14 -2.43 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $302.57 | 52 Week High | $139.79 | |||
| Open | $306.08 | 52 Week Low | $82.07 | |||
| Day High | $317.49 | P/E | 698.00 | |||
| Day Low | $297.31 | EPS | $0.43 | |||
| Volume | 393,775 | |||||

